Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ian Schoenhofen"'
Autor:
Janelle Sauvageau, Izel Koyuturk, Frank St. Michael, Denis Brochu, Marie-France Goneau, Ian Schoenhofen, Sylvie Perret, Alexandra Star, Anna Robotham, Arsalan Haqqani, John Kelly, Michel Gilbert, Yves Durocher
Publikováno v:
Communications Chemistry, Vol 6, Iss 1, Pp 1-13 (2023)
Abstract Glycosylation is a key quality attribute that must be closely monitored for protein therapeutics. Established assays such as HILIC-Fld of released glycans and LC-MS of glycopeptides work well for glycoproteins with a few glycosylation sites
Externí odkaz:
https://doaj.org/article/b6b1904909a242f99f4b91f266f9ce1c
Autor:
Mario Sanches, Igor D’Angelo, Maria Jaramillo, Jason Baardsnes, John Zwaagstra, Joe Schrag, Ian Schoenhofen, Mauro Acchione, Sam Lawn, Grant Wickman, Nina Weisser, David K. Y. Poon, Gordon Ng, Surjit Dixit
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
As biologics have become a mainstay in the development of novel therapies, protein engineering tools to expand on their structural advantages, namely specificity, affinity, and valency are of interest. Antibodies have dominated this field as the pref
Externí odkaz:
https://doaj.org/article/a5ed50a220974d43b325471bef850d35
Autor:
Grant Wickman, Sam Lawn, Joe Schrag, Gordon Yiu Kon Ng, Nina E. Weisser, David Kai Yuen Poon, Mario Sanches, Maria L. Jaramillo, Jason Baardsnes, Mauro Acchione, Igor Edmondo Paolo D'angelo, John C. Zwaagstra, Ian Schoenhofen, Surjit Bhimarao Dixit
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
As biologics have become a mainstay in the development of novel therapies, protein engineering tools to expand on their structural advantages, namely specificity, affinity, and valency are of interest. Antibodies have dominated this field as the pref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9914dffa3f6bcd78d30b1982a9e2e0f
https://doi.org/10.1080/19420862.2020.1802188
https://doi.org/10.1080/19420862.2020.1802188